Prescription Codes Activated at Seoul National University Hospital, Asan Medical Center

'JaQBo' Makes Entry into Major Hospitals, Targets GERD Market

'JaQBo(zastaprazan citrate)', South Korea's 37th domestically developed new drug, is gaining traction in major hospitals across the country. Developed by Onconic Therapeutics, a subsidiary of Jeil…

Comprehensive Review of UDCA Research, Including COVID-19 Prevention

Daewoong Pharmaceutical Publishes Updated Insights on UDCA

Daewoong Pharmaceutical has unveiled the third edition of its comprehensive guide, 'Updated Insights on Urusa' which highlights recent global research on ursodeoxycholic acid (UDCA), the main…

Tech Transfers Boost Orion’s Stock·Third-Gen Leader Rises

One Year After Acquiring LigaChem: Orion’s 'Golden Goose'?

On January 15, 2023, Orion announced the acquisition of a 25.73% stake in LigaChem Biosciences for KRW 584.8 billion (approximately USD 470 million). Orion participated in LigaChem's third-party share…